Elekta (OTCMKTS:EKTAY) Releases Quarterly Earnings Results

Elekta (OTCMKTS:EKTAY) announced its quarterly earnings data on Thursday. The company reported $0.07 earnings per share for the quarter, Zacks reports. Elekta had a positive return on equity of 11.11% and a negative net margin of 3.32%.

Elekta Stock Down 3.0%

Shares of OTCMKTS:EKTAY opened at $5.69 on Thursday. The company’s fifty day moving average is $5.18 and its 200-day moving average is $5.71. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.68 and a current ratio of 0.87. Elekta has a 52 week low of $4.35 and a 52 week high of $6.93. The company has a market capitalization of $2.10 billion, a PE ratio of -35.56 and a beta of 1.01.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of Elekta from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 28th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Reduce”.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.